| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
AVITA Medical (NASDAQ:RCEL) reported its Q4 earnings results on Thursday, February 22, 2024 at 04:01 PM.
Here's what investors need to know about the announcement.
AVITA Medical beat estimated earnings by 24.32%, reporting an EPS of $-0.28 versus an estimate of $-0.37.
Revenue was up $4.74 million from the same period last year.
Last quarter the company beat on EPS by $0.1 which was followed by a 14.27% increase in the share price the next day.
Here's a look at AVITA Medical's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.44 | -0.32 | -0.25 | -0.29 |
| EPS Actual | -0.34 | -0.41 | -0.37 | -0.21 |
| Revenue Estimate | 13.37M | 11.32M | 10.33M | 7.89M |
| Revenue Actual | 13.64M | 11.75M | 10.55M | 9.46M |
To track all earnings releases for AVITA Medical visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: RCEL
